Alimera Sciences Inc (ALIM)
3.31
-0.32
(-8.82%)
USD |
NASDAQ |
Apr 25, 16:00
Alimera Sciences Market Cap: 173.29M for April 25, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 173.29M |
| April 24, 2024 | 190.05M |
| April 23, 2024 | 187.95M |
| April 22, 2024 | 185.33M |
| April 19, 2024 | 174.86M |
| April 18, 2024 | 180.10M |
| April 17, 2024 | 185.86M |
| April 16, 2024 | 187.43M |
| April 15, 2024 | 185.33M |
| April 12, 2024 | 184.29M |
| April 11, 2024 | 201.56M |
| April 10, 2024 | 196.33M |
| April 09, 2024 | 198.95M |
| April 08, 2024 | 197.90M |
| April 05, 2024 | 201.56M |
| April 04, 2024 | 204.18M |
| April 03, 2024 | 206.80M |
| April 02, 2024 | 206.80M |
| April 01, 2024 | 201.56M |
| March 28, 2024 | 204.18M |
| March 27, 2024 | 204.18M |
| March 26, 2024 | 202.61M |
| March 25, 2024 | 208.89M |
| March 22, 2024 | 208.37M |
| March 21, 2024 | 210.47M |
| Date | Value |
|---|---|
| March 20, 2024 | 203.66M |
| March 19, 2024 | 212.04M |
| March 18, 2024 | 209.42M |
| March 15, 2024 | 220.41M |
| March 14, 2024 | 208.37M |
| March 13, 2024 | 199.99M |
| March 12, 2024 | 200.52M |
| March 11, 2024 | 197.38M |
| March 08, 2024 | 207.85M |
| March 07, 2024 | 204.18M |
| March 06, 2024 | 202.61M |
| March 05, 2024 | 197.90M |
| March 04, 2024 | 194.76M |
| March 01, 2024 | 194.24M |
| February 29, 2024 | 185.33M |
| February 28, 2024 | 174.86M |
| February 27, 2024 | 183.24M |
| February 26, 2024 | 176.96M |
| February 23, 2024 | 176.43M |
| February 22, 2024 | 173.29M |
| February 21, 2024 | 170.15M |
| February 20, 2024 | 178.01M |
| February 16, 2024 | 179.05M |
| February 15, 2024 | 178.01M |
| February 14, 2024 | 174.86M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
9.444M
Minimum
Mar 22 2023
226.44M
Maximum
Dec 29 2023
56.88M
Average
35.26M
Median
Mar 02 2020
Market Cap Benchmarks
| Eli Lilly and Co | 693.77B |
| NovaBay Pharmaceuticals Inc | 2.345M |
| Palatin Technologies Inc | 28.08M |
| iBio Inc | 5.993M |
| Theriva Biologics Inc | 7.202M |
Market Cap Related Metrics
| PS Ratio | 1.020 |
| Price to Book Value | 3.753 |
| Price | 3.31 |
| Earnings Yield | -65.32% |